Phenominer Database Results (24 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
SD heart rate artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 395.0 beats/min 5.0 12.25 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98799 2160
SD heart rate artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then xylazine (10 mg/kg) and ketamine (80 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 378.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98803 2160
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 9 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 7 460.0 beats/min 15.0 39.69 tail cuff plethysmography 0.0 acf 9 days 101375 2585
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 6 460.0 beats/min 9.0 22.05 tail cuff plethysmography 0.0 acf 4 days 101368 2585
WF/Mol heart rate controlled ramipril content drinking water (3 mg/kg/d) (for 10 days) then artificial aortocaval fistula (for 9 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 7 473.0 beats/min 20.0 52.92 tail cuff plethysmography 0.0 acf 9 days 101374 2585
WF/Mol heart rate controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 6 460.0 beats/min 5.0 12.25 tail cuff plethysmography 0.0 acf 7 days 101384 2585
SD heart rate artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72.0 days 5 367.0 beats/min 8.0 17.89 vascular transducer tipped catheter 0.0 ACF 2 days 99292 2278
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98.0 days 8 307.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99296 2278
SD heart rate artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 405.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98797 2160
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 5 470.0 beats/min 12.0 26.83 tail cuff plethysmography 0.0 acf 2 days 101378 2585
WF/Mol heart rate controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 5 450.0 beats/min 13.0 29.07 tail cuff plethysmography 0.0 acf 4 days 101366 2585
WF/Mol heart rate controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 7 443.0 beats/min 6.0 15.87 tail cuff plethysmography 0.0 acf 7 days 101370 2585
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98.0 days 8 271.0 beats/min 11.0 31.11 vascular transducer tipped catheter 0.0 ACF 28 days 99216 2278
SD heart rate artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 419.0 beats/min 21.0 51.44 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98795 2160
SD heart rate artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 436.0 beats/min 18.0 44.09 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98793 2160
SD heart rate artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male  days 6 420.0 beats/min 14.0 34.29 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98801 2160
WF/Mol heart rate controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 6 482.0 beats/min 12.0 29.39 tail cuff plethysmography 0.0 acf 2 days 101376 2585
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 7 450.0 beats/min 13.0 34.39 tail cuff plethysmography 0.0 acf 7 days 101372 2585
SD heart rate artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98.0 days 8 316.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99298 2278
WF/Mol heart rate controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 8 469.0 beats/min 10.0 28.28 tail cuff plethysmography 0.0 acf 4 days 101380 2585
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 6 448.0 beats/min 10.0 24.49 tail cuff plethysmography 0.0 acf 4 days 101382 2585
WF/Mol heart rate vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. heart pumping trait male  days 6 448.0 beats/min 7.0 17.15 tail cuff plethysmography 0.0 acf 7 days 101387 2585
SD heart rate artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 175.0 days 10 220.0 beats/min 5.0 15.81 vascular transducer tipped catheter 0.0 ACF 105 days 99218 2278
SD heart rate artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72.0 days 5 375.0 beats/min 12.0 26.83 vascular transducer tipped catheter 0.0 ACF 2 days 99294 2278